Europe Radioimmunoassay Market
市场规模（十亿美元）
CAGR :
% 
117.86
2023
2030
 Forecast Period |
2024 –2030 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
USD 117.86 |
 CAGR |
% |
| Major Markets Players |
欧洲放射免疫分析市场，按产品类型（放射免疫分析试剂和试剂盒以及放射免疫分析分析仪）、应用（科学研究和临床诊断）、最终用户（医院、临床诊断实验室、学术和研究机构、制药和生物制药行业、合同研究组织等）、分销渠道（直接招标、在线销售、第三方分销等）行业趋势和预测到 2030 年。
欧洲放射免疫分析市场分析与见解
由于各种疾病在医疗保健领域的患病率上升，医疗保健领域用于治疗目的的研究增加，以及使用用于检测的放射免疫分析试剂盒进行各种检测（如内分泌学和传染病），以及医疗保健支出增加也将推动业务增长。用于预先检测各种疾病的临床研究和实验室使市场得以扩大。
欧洲放射免疫分析市场预计将在 2023 年至 2030 年的预测期内增长。Data Bridge Market Research 分析称，在 2023 年至 2030 年的预测期内，该市场将以 4.0% 的复合年增长率增长，预计到 2030 年将达到 1.1786 亿美元。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制至 2020-2016) |
|
定量单位 |
收入（百万美元） |
|
涵盖的领域 |
按产品类型（放射免疫分析试剂和试剂盒和放射免疫分析分析仪）、应用（科学研究和临床诊断）、最终用户（医院、临床诊断实验室、学术和研究机构、制药和生物制药行业、合同研究组织等）、分销渠道（直接招标、在线销售、第三方分销等）。 |
|
覆盖国家 |
德国、法国、英国、意大利、西班牙、俄罗斯、土耳其、荷兰、比利时、瑞士和欧洲其他地区。 |
|
涵盖的市场参与者 |
参与该市场交易的主要公司包括同位素研究所、贝克曼库尔特公司、EUROIMMUN Medizinische Labordiagnostika AG、珀金埃尔默公司、默克集团、MyBioSource.com、Abcam plc.、Tecan Trading AG、Immuno-Biological Laboratories Co,Ltd.、MPBIOMEDICALS、DiaSource、Berthold Technologies GmbH & Co.KG 和 Hidex Oy 等。 |
市场定义
放射免疫分析是一种异质分析，采用放射性标记药物（通常为 125i），竞争性结合分析理论是放射免疫分析的基础。在这种方法中，抗原和抗体相互结合，放射免疫分析用于确定抗原结合量。借助抗体，这种方法的超敏性使其能够检测出哪怕是最微量的激素或药物水平。
由于各种疾病在医疗保健领域的患病率上升，医疗保健领域用于治疗目的的研究增加，以及使用放射免疫分析试剂盒进行内分泌学和传染病等各种检测以及医疗保健支出的增加也将推动业务增长。用于预先测试各种疾病的临床研究和实验室使市场得以扩大。
随着癌症和感染等严重疾病的增多以及医疗保健意识的提高，实验室检测的增长导致对各种检测试剂盒的需求增加。这方面也导致了对试剂和试剂盒的需求增加。
由于市场参与者的增加以及先进试剂盒和分析仪的供应，欧洲放射免疫分析市场在预测年内将不断增长。与此同时，制造商也致力于研发活动，以将产品推向市场。不断增加的研发和预测试进一步促进了市场的增长。然而，另一种免疫分析测试技术占据了放射免疫分析的主导地位，这可能会阻碍预测期内欧洲放射免疫分析市场的增长。
欧洲放射免疫分析市场动态
本节旨在了解市场驱动因素、机遇、限制因素和挑战。下文将详细讨论所有这些内容：
驱动程序
对高通量和自动化程序的无错误和准确结果的需求增加
放射免疫分析是一种异质分析，采用放射性标记药物（通常为 125i），竞争性结合分析理论是放射免疫分析的基础。在这种方法中，抗原和抗体相互结合，放射免疫分析用于确定结合了多少抗原。
因此，由于此类严重疾病和病毒的数量不断增加，近年来生物模型的增长非常迅速。这增加了对生物样本无错误和准确结果的需求。
传染病患病率和发病率上升
传染病是由有害物质（病原体）进入人体引起的疾病。最常见的病因是病毒、细菌、真菌和寄生虫。传染病通常通过受污染的食物或水以及虫咬在人与人之间传播。有些传染病很轻微，有些则非常严重。
因此，近年来，传染病例数量不断增加，生物模型数量大幅增加。这导致对用于检测和研究这些方面的各种放射免疫分析技术的需求增加，预计这将推动未来几年市场的增长。
限制
放射免疫分析试剂盒的安装和维护成本高
放射免疫分析试剂盒的成本对市场来说是一个重大挫折，因为预计高成本会导致需求减少。
因此，生命科学领域的研究和开发不断增加，导致放射免疫分析技术取得更多进步。这种进步不断提高放射免疫分析及其装置的价格，这可能会阻碍欧洲放射免疫分析市场的增长。
放射性标记化合物的保质期短
化合物在储存过程中会随时间分解。分解速度因化合物而异。然而，由于放射性分解，用放射性同位素标记的化合物通常比未标记的化合物分解得更快。
因此，在放射免疫分析技术中，需要格外小心放射性标记同位素的储存使用，以防止其分解成为欧洲放射免疫分析市场的一个制约因素。
机遇/挑战
缺乏熟练的专业人员
放射免疫分析技术非常先进，灵敏度足够高，可以发现血液中的小分子。因此，它可用于研究目的和诊断癌症等疾病。组织和研究实验室也将这种技术用于使用动物或人类血清的特定研究目的。然而，缺乏无法使用这些仪器的合格人员可能会在预测期内抑制放射免疫分析市场的增长。
此外，该领域的技术快速进步也导致缺乏熟练的专业人员。缺乏熟练的专业人员在处理全球设备时构成了重大挑战。
最新动态
- 2022年4月，领先的科技公司默克宣布了多项组织变革和新的运营模式，以支持生命科学业务部门的长期增长战略，更好地服务客户不断变化的需求。此举有助于该公司扩大其生命科学业务部门。
- 2022 年 6 月，PerkinElmer, Inc. 旗下公司 EUROIMMUN 宣布推出两种获得 CE 标志的检测方法——抗 SARS-CoV-2 RBD ChLIA (IgG) 和抗 SARS-CoV-2 Omicron ELISA (IgG)。这两种检测系统都可以检测针对 SARS-CoV-2 形成的 IgG 抗体，并可供接受 CE 标志的国家/地区的实验室使用。这有助于该公司扩大其在市场上的业务。
欧洲放射免疫分析市场范围
欧洲放射免疫分析市场分为产品类型、应用、最终用户和分销渠道。这些细分市场之间的增长将帮助您分析行业中的主要增长细分市场，并为用户提供有价值的市场概览和市场洞察，以便做出战略决策，确定核心市场应用。
按产品类型
- 放射免疫分析试剂和试剂盒
- 放射免疫分析仪
根据产品类型，欧洲放射免疫分析市场分为放射免疫分析试剂和试剂盒以及放射免疫分析分析仪。
按应用
- 临床诊断
- 科学研究
根据应用，欧洲放射免疫分析市场分为临床诊断和科学研究。
按最终用户
- 医院
- 临床诊断实验室
- 学术及研究机构
- 制药及生物制药行业
- 合同研究组织
- 其他的
根据最终用户，欧洲放射免疫分析市场分为医院、临床诊断实验室、学术和研究机构、制药和生物制药行业、合同研究组织等。
按分销渠道
- 直接招标
- 网上销售
- 第三方发行版
- 其他的
根据分销渠道，欧洲放射免疫分析市场分为直接招标、在线销售、第三方分销和其他。
欧洲放射免疫分析市场区域分析/见解
对欧洲放射免疫分析市场进行了分析，并按产品类型、应用、最终用户和分销渠道提供了市场规模洞察和趋势，如上所述。
德国在市场份额和收入方面占据欧洲放射免疫分析市场的主导地位，并将在预测期内继续保持主导地位。这是由于该地区显微镜技术不断进步，不断增长的研发投资和新产品的推出正在推动市场发展
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场法规变化。新旧销售、国家人口统计、疾病流行病学和进出口关税等数据点是预测各个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了欧洲品牌的存在和可用性以及它们因本土和国内品牌的竞争而面临的挑战以及销售渠道的影响。
竞争格局和欧洲放射免疫分析市场份额分析
放射免疫分析市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、欧洲业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上数据点仅与专注于放射免疫分析市场的公司有关。
欧洲放射免疫分析市场的一些主要参与者包括 Isotopes、Beckman Coulter, Inc.、EUROIMMUN Medizinische Labordiagnostika AG、PerkinElmer Inc.、Merck KGaA、MyBioSource.com.、Abcam plc.、Tecan Trading AG、Immuno-Biological Laboratories Co,Ltd.、MPBIOMEDICALS、DiaSource、Berthold Technologies GmbH & Co.KG 和 Hidex Oy. 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE RADIOIMMUNOASSAY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET TESTING TYPE COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTYER’S FIVE FORCES
4.3 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS
5 INDUSTRY INSIGHTS:
6 REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY
6.1 U.S REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY
6.2 EUROPE REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY
6.3 INDIA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY
6.4 CHINA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASE IN THE DEMAND FOR ERROR-FREE AND ACCURATE RESULTS OF HIGH THROUGHPUT AND AUTOMATED PROCEDURES
7.1.2 RISE IN THE PREVALENCE AND INCIDENCE OF INFECTIOUS DISEASES
7.1.3 RISE IN THE TECHNOLOGICAL ADVANCEMENTS
7.2 RESTRAINTS
7.2.1 HIGH COST OF INSTALLATION AND MAINTENANCE OF RADIOIMMUNOASSAY KITS
7.2.2 SHORT SHELF-LIFE OF RADIOLABELED COMPOUNDS
7.2.3 ADVERSE EFFECTS OF HAZARDOUS RADIOACTIVE ELEMENTS
7.3 OPPORTUNITIES
7.3.1 INCREASING SIGNIFICANCE OF RESEARCH AND DEVELOPMENT IN MEDICAL SCIENCE
7.3.2 RISE IN GOVERNMENT FUNDING AND OVERALL HEALTHCARE EXPENDITURE
7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
7.4 CHALLENGES
7.4.1 LACK OF SKILLED PROFESSIONALS
7.4.2 NEW INNOVATIONS IN VARIOUS OTHER IMMUNOASSAY PROCEDURES
8 EUROPE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 RADIOIMMUNOASSAY REAGENTS AND KITS
8.2.1 KITS
8.2.2 BUFFER
8.2.2.1 SOLUTION
8.2.2.2 POWDER
8.2.3 STANDARD CONCENTRATES
8.2.4 PRECIPITATING REAGENTS
8.2.5 RADIOISOTOPES
8.2.5.1 BETA EMITTERS
8.2.5.1.1 TRITIUM
8.2.5.1.2 CARBON-14
8.2.5.2 GAMMA EMITTERS
8.2.5.2.1 IODINE-125
8.2.5.2.2 CHROMIUM-51
8.2.5.2.3 COBALT-57
8.2.6 ANTIBODY/ANTISERUM
8.2.6.1 POLYCLONAL
8.2.6.2 MONOCLONAL
8.2.7 OTHERS
8.3 RADIOIMMUNOASSAY ANALYZER
9 EUROPE RADIOIMMUNOASSAY MARKET: BY APPLICATION
9.1 OVERVIEW
9.2 SCIENTIFIC RESEARCH
9.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS
9.2.2 RADIOIMMUNOASSAY ANALYZER
9.3 CLINICAL DIAGNOSIS
9.3.1 INFECTIOUS DISEASE TESTING
9.3.1.1 RADIOIMMUNOASSAY REAGENTS AND KITS
9.3.1.2 RADIOIMMUNOASSAY ANALYZER
9.3.2 ALLERGY TESTING
9.3.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS
9.3.2.2 RADIOIMMUNOASSAY ANALYZER
9.3.3 ONCOLOGY TESTING
9.3.3.1 RADIOIMMUNOASSAY REAGENTS AND KITS
9.3.3.2 RADIOIMMUNOASSAY ANALYZER
9.3.4 ENDOCRINE TESTING
9.3.4.1 RADIOIMMUNOASSAY REAGENTS AND KITS
9.3.4.2 RADIOIMMUNOASSAY ANALYZER
9.3.5 TOXICOLOGY TESTING
9.3.5.1 RADIOIMMUNOASSAY REAGENTS AND KITS
9.3.5.2 RADIOIMMUNOASSAY ANALYZER
9.3.6 AUTOIMMUNE DISEASE TESTING
9.3.6.1 RADIOIMMUNOASSAY REAGENTS AND KITS
9.3.6.2 RADIOIMMUNOASSAY ANALYZER
9.3.7 OTHER DISEASE TESTING
10 EUROPE RADIOIMMUNOASSAY MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 CLINICAL DIAGNOSTIC LABORATORIES
10.4 ACADEMIC AND RESEARCH INSTITUTES
10.5 PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY
10.6 CONTRACT RESEARCH ORGANISATIONS
10.7 OTHERS
11 EUROPE RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 ONLINE SALES
11.4 THIRD PARTY DISTRIBUTIONS
11.5 OTHERS
12 EUROPE RADIOIMMUNOASSAY MARKET, BY REGION
12.1 EUROPE
12.1.1 GERMANY
12.1.2 FRANCE
12.1.3 U.K.
12.1.4 ITALY
12.1.5 SPAIN
12.1.6 RUSSIA
12.1.7 TURKEY
12.1.8 NETHERLANDS
12.1.9 BELGIUM
12.1.10 SWITZERLAND
12.1.11 REST OF EUROPE
13 EUROPE RADIOIMMUNOASSAY MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EUROPE
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 PERKINELMER INC.
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.4 RECENT DEVELOPMENT
15.2 MERCK KGAA
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 BECKMAN COULTER, INC.
15.3.1 COMPANY SNAPSHOT
15.3.2 COMPANY SHARE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENT
15.4 ABCAM PLC
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 TECAN TRADING AG
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 BERTHOLD TECHNOLOGIES GMBH & CO.KG
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENTS
15.7 DEMEDITEC DIAGNOSTICS GMBH
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENTS
15.8 DIASOURCE
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENTS
15.1 HIDEX OY
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENTS
15.11 IMMUNO-BIOLOGICAL LABORATORIES CO,LTD.
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 INSTITUTE OF ISOTOPES
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENTS
15.13 KAMIYA BIOMEDICAL COMPANY
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENTS
15.14 MP BIOMEDICALS
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENTS
15.15 MYBIOSOURCE.COM.
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
表格列表
TABLE 1 LIST OF IN-VITRO DIAGNOSTIC MEDICAL DEVICES (IVD ANALYZERS) UNDER PROVISIONS OF SUB-RULE (2) RULE 4 OF THE MEDICAL DEVICES RULES, 2017
TABLE 2 COST OF RIA KITS IS MENTIONED BELOW
TABLE 3 DECOMPOSITION RATES OF A FEW RADIOLABELED ISOTOPES ARE MENTIONED IN THE BELOW TABLE
TABLE 4 EUROPE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 5 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 7 EUROPE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 EUROPE RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 9 EUROPE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 10 EUROPE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 EUROPE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 12 EUROPE RADIOIMMUNOASSAY ANALYZER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 EUROPE RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 14 EUROPE SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 EUROPE SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 16 EUROPE CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 EUROPE CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 18 EUROPE INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 19 EUROPE ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 20 EUROPE ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 21 EUROPE ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 22 EUROPE TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 23 EUROPE AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 24 EUROPE RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 25 EUROPE HOSPITALS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 EUROPE CLINICAL DIAGNOSTIC LABORATORIES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 EUROPE ACADEMIC AND RESEARCH INSTITUTES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 EUROPE PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 EUROPE CONTRACT RESEARCH ORGANISATIONS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 EUROPE OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 EUROPE RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 32 EUROPE DIRECT TENDER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 EUROPE ONLINE SALES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 34 EUROPE THIRD PARTY DISTRIBUTION IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 35 EUROPE OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 EUROPE RADIOIMMUNOASSAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 37 EUROPE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 38 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 39 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 40 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 41 EUROPE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 42 EUROPE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 43 EUROPE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 44 EUROPE RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 45 EUROPE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 46 EUROPE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 47 EUROPE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 48 EUROPE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 49 EUROPE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 50 EUROPE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 51 EUROPE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 52 EUROPE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 53 EUROPE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 54 EUROPE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 55 EUROPE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 56 EUROPE RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 57 EUROPE SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 58 EUROPE CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 59 EUROPE INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 60 EUROPE ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 61 EUROPE ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 62 EUROPE ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 63 EUROPE TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 64 EUROPE AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 65 EUROPE RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 66 EUROPE RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 67 GERMANY RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 68 GERMANY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 69 GERMANY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 70 GERMANY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 71 GERMANY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 72 GERMANY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 73 GERMANY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 74 GERMANY RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 75 GERMANY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 76 GERMANY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 77 GERMANY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 78 GERMANY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 79 GERMANY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 80 GERMANY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 81 GERMANY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 82 GERMANY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 83 GERMANY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 84 GERMANY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 85 GERMANY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 86 GERMANY RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 87 GERMANY SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 88 GERMANY CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 89 GERMANY INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 90 GERMANY ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 91 GERMANY ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 92 GERMANY ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 93 GERMANY TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 94 GERMANY AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 95 GERMANY RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 96 GERMANY RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 97 FRANCE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 98 FRANCE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 99 FRANCE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 100 FRANCE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 101 FRANCE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 102 FRANCE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 103 FRANCE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 104 FRANCE RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 105 FRANCE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 106 FRANCE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 107 FRANCE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 108 FRANCE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 109 FRANCE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 110 FRANCE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 111 FRANCE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 112 FRANCE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 113 FRANCE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 114 FRANCE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 115 FRANCE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 116 FRANCE RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 117 FRANCE SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 118 FRANCE CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 119 FRANCE INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 120 FRANCE ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 121 FRANCE ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 122 FRANCE ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 123 FRANCE TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 124 FRANCE AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 125 FRANCE RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 126 FRANCE RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 127 U.K. RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 128 U.K. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 129 U.K. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 130 U.K. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 131 U.K. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 132 U.K. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 133 U.K. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 134 U.K. RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 135 U.K. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 136 U.K. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 137 U.K. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 138 U.K. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 139 U.K. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 140 U.K. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 141 U.K. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 142 U.K. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 143 U.K. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 144 U.K. RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 145 U.K. RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 146 U.K. RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 147 U.K. SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 148 U.K. CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 149 U.K. INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 150 U.K. ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 151 U.K. ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 152 U.K. ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 153 U.K. TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 154 U.K. AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 155 U.K. RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 156 U.K. RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 157 ITALY RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 158 ITALY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 159 ITALY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 160 ITALY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 161 ITALY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 162 ITALY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 163 ITALY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 164 ITALY RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 165 ITALY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 166 ITALY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 167 ITALY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 168 ITALY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 169 ITALY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 170 ITALY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 171 ITALY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 172 ITALY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 173 ITALY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 174 ITALY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 175 ITALY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 176 ITALY RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 177 ITALY SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 178 ITALY CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 179 ITALY INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 180 ITALY ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 181 ITALY ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 182 ITALY ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 183 ITALY TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 184 ITALY AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 185 ITALY RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 186 ITALY RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 187 SPAIN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 188 SPAIN RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 189 SPAIN RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 190 SPAIN RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 191 SPAIN BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 192 SPAIN BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 193 SPAIN BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 194 SPAIN RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 195 SPAIN BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 196 SPAIN BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 197 SPAIN BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 198 SPAIN GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 199 SPAIN GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 200 SPAIN GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 201 SPAIN ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 202 SPAIN ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 203 SPAIN ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 204 SPAIN RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 205 SPAIN RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 206 SPAIN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 207 SPAIN SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 208 SPAIN CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 209 SPAIN INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 210 SPAIN ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 211 SPAIN ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 212 SPAIN ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 213 SPAIN TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 214 SPAIN AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 215 SPAIN RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 216 SPAIN RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 217 RUSSIA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 218 RUSSIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 219 RUSSIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 220 RUSSIA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 221 RUSSIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 222 RUSSIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 223 RUSSIA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 224 RUSSIA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 225 RUSSIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 226 RUSSIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 227 RUSSIA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 228 RUSSIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 229 RUSSIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 230 RUSSIA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 231 RUSSIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 232 RUSSIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 233 RUSSIA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 234 RUSSIA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 235 RUSSIA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 236 RUSSIA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 237 RUSSIA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 238 RUSSIA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 239 RUSSIA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 240 RUSSIA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 241 RUSSIA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 242 RUSSIA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 243 RUSSIA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 244 RUSSIA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 245 RUSSIA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 246 RUSSIA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 247 TURKEY RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 248 TURKEY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 249 TURKEY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 250 TURKEY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 251 TURKEY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 252 TURKEY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 253 TURKEY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 254 TURKEY RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 255 TURKEY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 256 TURKEY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 257 TURKEY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 258 TURKEY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 259 TURKEY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 260 TURKEY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 261 TURKEY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 262 TURKEY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 263 TURKEY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 264 TURKEY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 265 TURKEY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 266 TURKEY RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 267 TURKEY INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 268 TURKEY ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 269 TURKEY ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 270 TURKEY ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 271 TURKEY TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 272 TURKEY AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 273 TURKEY RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 274 TURKEY RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 275 NETHERLANDS RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 276 NETHERLANDS RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 277 NETHERLANDS RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 278 NETHERLANDS RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 279 NETHERLANDS BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 280 NETHERLANDS BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 281 NETHERLANDS BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 282 NETHERLANDS RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 283 NETHERLANDS BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 284 NETHERLANDS BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 285 NETHERLANDS BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 286 NETHERLANDS GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 287 NETHERLANDS GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 288 NETHERLANDS GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 289 NETHERLANDS ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 290 NETHERLANDS ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 291 NETHERLANDS ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 292 NETHERLANDS RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 293 NETHERLANDS RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 294 NETHERLANDS RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 295 NETHERLANDS SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 296 NETHERLANDS CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 297 NETHERLANDS INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 298 NETHERLANDS ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 299 NETHERLANDS ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 300 NETHERLANDS ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 301 NETHERLANDS TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 302 NETHERLANDS AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 303 NETHERLANDS RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 304 NETHERLANDS RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 305 BELGIUM RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 306 BELGIUM RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 307 BELGIUM RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 308 BELGIUM RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 309 BELGIUM BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 310 BELGIUM BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 311 BELGIUM BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 312 BELGIUM RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 313 BELGIUM BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 314 BELGIUM BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 315 BELGIUM BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 316 BELGIUM GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 317 BELGIUM GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 318 BELGIUM GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 319 BELGIUM ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 320 BELGIUM ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 321 BELGIUM RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 322 BELGIUM RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 323 BELGIUM RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 324 BELGIUM SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 325 BELGIUM CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 326 BELGIUM INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 327 BELGIUM ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 328 BELGIUM ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 329 BELGIUM ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 330 BELGIUM TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 331 BELGIUM AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 332 BELGIUM RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 333 BELGIUM RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 334 SWITZERLAND RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 335 SWITZERLAND RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 336 SWITZERLAND RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 337 SWITZERLAND RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 338 SWITZERLAND BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 339 SWITZERLAND BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 340 SWITZERLAND BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 341 SWITZERLAND RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 342 SWITZERLAND BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 343 SWITZERLAND BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 344 SWITZERLAND BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 345 SWITZERLAND GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 346 SWITZERLAND GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 347 SWITZERLAND GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 348 SWITZERLAND ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION)
TABLE 349 SWITZERLAND ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME)
TABLE 350 SWITZERLAND ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD)
TABLE 351 SWITZERLAND RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 352 SWITZERLAND RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)
TABLE 353 SWITZERLAND RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 354 SWITZERLAND SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 355 SWITZERLAND CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 356 SWITZERLAND INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 357 SWITZERLAND ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 358 SWITZERLAND ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 359 SWITZERLAND ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 360 SWITZERLAND TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 361 SWITZERLAND AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 362 SWITZERLAND RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 363 SWITZERLAND RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 364 REST OF EUROPE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
图片列表
FIGURE 1 EUROPE RADIOIMMUNOASSAY MARKET: SEGMENTATION
FIGURE 2 EUROPE RADIOIMMUNOASSAY MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE RADIOIMMUNOASSAY MARKET: DROC ANALYSIS
FIGURE 4 EUROPE RADIOIMMUNOASSAY MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE RADIOIMMUNOASSAY: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE RADIOIMMUNOASSAY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE RADIOIMMUNOASSAY MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE RADIOIMMUNOASSAY MARKET: MARKET TESTING TYPE COVERAGE GRID
FIGURE 9 EUROPE RADIOIMMUNOASSAY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE RADIOIMMUNOASSAY MARKET: SEGMENTATION
FIGURE 11 RISING PREVALENCE AND INCIDENCE OF INFECTIOUS DISEASES ARE EXPECTED TO DRIVE THE EUROPE RADIOIMMUNOASSAY MARKET IN THE FORECAST PERIOD
FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE RADIOIMMUNOASSAY MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE RADIOIMMUNOASSAY MARKET
FIGURE 14 EUROPE RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, 2022
FIGURE 15 EUROPE RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 EUROPE RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 EUROPE RADIOIMMUNOASSAY MARKET: PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 EUROPE RADIOIMMUNOASSAY MARKET: BY APPLICATION, 2022
FIGURE 19 EUROPE RADIOIMMUNOASSAY MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 20 EUROPE RADIOIMMUNOASSAY MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 21 EUROPE RADIOIMMUNOASSAY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 22 EUROPE RADIOIMMUNOASSAY MARKET: BY END USER, 2022
FIGURE 23 EUROPE RADIOIMMUNOASSAY MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 24 EUROPE RADIOIMMUNOASSAY MARKET: BY END USER, CAGR (2023-2030)
FIGURE 25 EUROPE RADIOIMMUNOASSAY MARKET : BY END USER, LIFELINE CURVE
FIGURE 26 EUROPE RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 27 EUROPE RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 28 EUROPE RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 29 EUROPE RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 30 EUROPE RADIOIMMUNOASSAY MARKET: SNAPSHOT (2022)
FIGURE 31 EUROPE RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022)
FIGURE 32 EUROPE RADIOIMMUNOASSAY MARKET: BY COUNTRY (2023 & 2030)
FIGURE 33 EUROPE RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022 & 2030)
FIGURE 34 EUROPE RADIOIMMUNOASSAY MARKET: PRODUCT TYPE (2023-2030)
FIGURE 35 EUROPE RADIOIMMUNOASSAY MARKET: COMPANY SHARE 2022 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
